Neither Anderson Silva nor Nick Diaz will appear before the NAC on Monday. | Dave Mandel/Sherdog.com
Anderson Silva and Nick Diaz have been granted continuances by the Nevada Athletic Commission and will not face disciplinary action for at least another month.
The UFC 183 combatants were initially scheduled to appear before the commission on Monday, but Sherdog.com confirmed with NAC Executive Director Bob Bennett that hearings for both Silva and Diaz will be postponed at least until April.
Brazilian media outlet Combate first reported the news regarding Silva, while MMAFighting.com initially brought word of Diaz’s request. Both Silva and Diaz are facing long-term suspensions and fines. The result of their UFC 183 bout, which Silva won via unanimous decision, could be changed to a no contest.
Both fighters were issued temporary suspensions by the NAC on Feb. 17.
Silva tested positive for two different anabolic steroids -- drostanolone metabolites and androsterone -- during a pre-fight drug test administered ahead of his bout with Diaz on Jan. 9. The former middleweight champion also tested positive for Oxazepam and Temazepam in a post-fight urine test administered on Jan. 31. Oxazepam is used to relieve anxiety, while Temazepam is an anti-insomnia medication. In addition, “The Spider” again tested positive from drostanolone metabolites.
Diaz, meanwhile, tested positive for marijuana in a post-fight drug test following the UFC 183 main event. The Stockton, Calif., resident’s urine sample had 300 nanograms per milliliter of marijuana metabolites, which is double the NAC’s allowable limit of 150 ng/mL. It was Diaz’s third positive test for marijuana in Nevada.
While neither Silva nor Diaz will appear at Monday’s NAC meeting, Hector Lombard remains on the agenda, according to Bennett. The Cuban welterweight tested positive for the steroid desoxymethyltestosterone (DMT) after a unanimous decision victory over Josh Burkman at UFC 182 on Jan. 3.